Last quarter (Q ), IVERIC bio's total revenue was $―, a decrease of ― from the same quarter last year. In Q, IVERIC bio's net income was $-72.23M. See IVERIC bio’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 22	Dec 21	Dec 20	Dec 19	Dec 18
Total Revenue	-	-	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Cost of Revenue	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-
Operating Expense	$ 103.14M	$ -189.91M	$ 114.76M	$ 88.74M	$ 61.27M	$ 65.35M
Operating Income	$ -229.08M	$ -189.91M	$ -114.76M	$ -88.74M	$ -61.27M	$ -65.35M
Net Non Operating Interest Income Expense	$ 5.59M	$ 2.26M	$ 245.00K	$ 500.00K	$ 2.15M	$ 2.39M
Other Income Expense	$ -643.00K	$ -2.43M	$ -10.00K	$ -6.00K	$ 151.00K	$ 124.98M
Pretax Income	$ -222.90M	$ -185.21M	$ -114.52M	$ -88.24M	$ -58.97M	$ 62.02M
Tax Provision	-	-	$ 0.00	$ -3.69M	$ -111.00K	$ -1.06M
Earnings From Equity Interest Net Of Tax	-	-	-	-	-	-
Net Income Common Stockholders	$ -222.90M	$ -185.21M	$ -114.52M	$ -84.55M	$ -58.86M	$ 63.09M
Basic EPS	$ -1.77	$ -1.53	$ -1.12	$ -1.14	$ -1.39	$ 1.70
Diluted EPS	$ -1.77	$ -1.53	$ -1.12	$ -1.14	$ -1.39	$ 1.70
Basic Average Shares	$ 498.09M	$ 121.04M	$ 101.87M	$ 74.19M	$ 42.22M	$ 37.06M
Diluted Average Shares	$ 498.09M	$ 121.04M	$ 101.87M	$ 74.19M	$ 42.22M	$ 37.09M
Dividend Per Share	-	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-	-
Rent Expense Supplemental	-	-	-	-	-	-
Total Expenses	$ 103.14M	$ -189.91M	$ 114.76M	$ 88.74M	$ 61.27M	$ 65.35M
Net Income From Continuing And Discontinued Operation	$ -222.90M	$ -185.21M	$ -114.52M	$ -84.55M	$ -58.86M	$ 63.09M
Normalized Income	$ -91.61M	-	$ -114.52M	$ -84.55M	$ -58.86M	$ -28.16M
Interest Expense	-	-	-	-	-	-
EBIT	$ -228.47M	$ -187.47M	$ -114.76M	$ -88.74M	$ -61.27M	$ -65.35M
EBITDA	$ -229.30M	$ -186.87M	$ -114.72M	$ -88.59M	$ -61.11M	$ -65.17M

Currency in USD

IVERIC bio Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing